Cowen and Company’s Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share KLR.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-67,944
Closed -$102K 665
2020
Q4
$102K Sell
67,944
-15,945
-19% -$23.1K 0.01% 221
2020
Q3
$119K Sell
83,889
-35,267
-30% -$31K 0.02% 246
2020
Q2
$77K Buy
119,156
+3,800
+3% +$3.22K 0.01% 255
2020
Q1
$98K Buy
115,356
+47,412
+70% +$49.6K 0.02% 248
2019
Q4
$77K Buy
+67,944
New +$61.1K 0.01% 283

Other funds holding KLR.WS

Cowen and Company's KLR.WS Position: Q1 2021 in Review

Cowen and Company sold out of Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share (KLR.WS) in Q1 2021, closing a stake of 67,944 shares — an estimated $102K sold.

Cowen and Company first reported a position in KLR.WS in Q4 2019 and held it in 5 quarters. The position peaked at $119K in Q3 2020. 11 funds tracked by Wall St. Rank hold KLR.WS as of Q1 2021.

  • Cowen and Company reported no remaining Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position as of Q1 2021 after selling out during the quarter.
  • Cowen and Company sold 67,944 Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share shares in Q1 2021, an estimated $102K.
  • Cowen and Company first reported a position in Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share in Q4 2019 and held it in 5 quarters.
  • Cowen and Company's Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position peaked at $119K in Q3 2020.
  • 11 funds tracked by Wall St. Rank held Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share as of Q1 2021.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.